Spots Global Cancer Trial Database for effects of immunotherapy
Every month we try and update this database with for effects of immunotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma | NCT02406183 | Melanoma Effects of Immu... Adverse Effect ... | Stereotactic bo... Ipilimumab | 18 Years - | University Hospital, Ghent | |
Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma | NCT01863108 | Melanoma Tumor Vaccines Effects of Immu... | GeniusVac-Mel4 | 18 Years - | University Hospital, Grenoble | |
Study on TIL Engineered With Membrane-Binding Cytokine for the Treatment of Advanced Gynecologic Tumors | NCT05468307 | Advanced Gyneco... TIL Engineered ... Treatment Side ... Effects of Immu... | Membrane Bound ... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia | NCT01513109 | Acute Myelogeno... Myeloid Leukemi... Effects of Immu... | Recombinant WT1... | 18 Years - | Jules Bordet Institute | |
A Clinical Study on TIL for the Treatment of Advanced Solid Tumors | NCT05087745 | Advanced Solid ... Tumor Infiltrat... Treatment Side ... Effects of Immu... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma | NCT02169609 | Neuroblastoma Neoplasm, Resid... Effects of Immu... | Dinutuximab. Im... | - | Fundació Sant Joan de Déu | |
Study on TIL for the Treatment of Advanced Breast Cancer | NCT05142475 | Breast Cancer Treatment Side ... Advanced Breast... Effects of Immu... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
Study on Signal Switch Receptor Modified TIL for the Treatment of Advanced Gynecologic Tumors | NCT05098171 | Advanced Gyneco... Signal Switch R... Treatment Side ... Effects of Immu... | Signal Switch R... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC | NCT05420922 | Hepatocellular ... Programmed Cell... Effects of Immu... | Lenvatinib Oral... PD-1 inhibitor Local treatment | 18 Years - | Tongji Hospital | |
Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC | NCT05420922 | Hepatocellular ... Programmed Cell... Effects of Immu... | Lenvatinib Oral... PD-1 inhibitor Local treatment | 18 Years - | Tongji Hospital | |
Impact of Gonadotoxic Therapies on Fertility | NCT05885048 | Cancer Fertility Issue... Fertility Prese... Toxicity Due to... Toxicity Due to... Effects of Immu... | Blood samples f... Sperm samples f... Satisfaction ev... Quality of Life... | 14 Years - 50 Years | Universitätsklinik fur Frauenheilkunde, Inselspital Bern | |
Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma | NCT02765243 | Neuroblastoma Effects of Immu... | Anti-GD2 CART | 1 Year - 14 Years | Zhujiang Hospital | |
Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma | NCT02765243 | Neuroblastoma Effects of Immu... | Anti-GD2 CART | 1 Year - 14 Years | Zhujiang Hospital | |
Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC | NCT05420922 | Hepatocellular ... Programmed Cell... Effects of Immu... | Lenvatinib Oral... PD-1 inhibitor Local treatment | 18 Years - | Tongji Hospital | |
Study on TIL for the Treatment of Advanced Hepatobiliary-Pancreatic Cancers | NCT05098197 | Advanced Liver ... Tumor Infiltrat... Treatment Side ... Effects of Immu... Advanced Pancre... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics |